CC BY 4.0 · Journal of Digestive Endoscopy 2024; 15(02): 141-144
DOI: 10.1055/s-0044-1785223
Endoscopy Video

Rare Cause of Sphincter of Oddi Dysfunction and Double Duct Sign

Akash Goel
1   Department of Gastroenterology, Hepatology and Endoscopy, Max Superspeciality Hospital, Saket, Delhi, India
,
1   Department of Gastroenterology, Hepatology and Endoscopy, Max Superspeciality Hospital, Saket, Delhi, India
,
Sawan Bopanna
1   Department of Gastroenterology, Hepatology and Endoscopy, Max Superspeciality Hospital, Saket, Delhi, India
,
Pankaj Singh
1   Department of Gastroenterology, Hepatology and Endoscopy, Max Superspeciality Hospital, Saket, Delhi, India
,
Muzaffer Rashid Shawl
1   Department of Gastroenterology, Hepatology and Endoscopy, Max Superspeciality Hospital, Saket, Delhi, India
› Author Affiliations
Funding None.
 

Abstract

Double duct sign on imaging is defined as dilated common bile duct and pancreatic duct till ampulla and is usually associated with an ampullary obstruction likely periampullary malignancy. Sphincter of Oddi dysfunction is an uncommon cause of double duct sign. In the present case, we are discussing a rare cause of Sphincter of Oddi dysfunction with double duct sign.


#

Introduction

Dilatation of the common bile duct (CBD) along with pancreatic duct (PD) is an important radiological sign suggesting an obstruction at the distal portion of both the CBD and PD.[1] The presence of a double duct sign should ensure a careful search for underlying etiology. Though periampullary malignancy is the most common cause, benign diseases such as chronic pancreatitis and sphincter of Oddi dysfunction (SOD) can also lead to double duct sign. SOD is due to a functional obstruction at papilla and high index of suspicion is required for diagnosing this condition after ruling out other structural causes. We hereby report a rare cause of SOD giving rise to a double duct sign.[2]


#

Case Presentation

A 57-year-old male businessman presented with complaints of episodes of noncolicky epigastric pain, without any history of fever, jaundice, or weight loss. Each episode used to last 5 to 6 hours with either spontaneous improvement or with parenteral analgesics. Clinical examination was unremarkable without any icterus or abdominal lump. Blood investigations revealed elevated liver enzymes that were suggestive of cholestatic/obstructive pattern. Serum bilirubin value was normal (1.2 mg/dL), and serum alkaline phosphatase, gamma glutamyl transpeptidase, serum glutamic pyruvic transaminase, and serum glutamic-oxaloacetic transaminase values were 579 IU/L, 2,309 IU/L, 249 IU/L, and 186 IU/L, respectively. Ca 19-9 was elevated to two times the upper limit of normal. Viral markers hepatitis B surface antigen, anti-hepatitis C virus, immunoglobulin M (IgM) anti-hepatitis A virus, IgM anti-hepatitis E virus were negative. Ultrasound (US) abdomen revealed dilated CBD measuring 12 mm till the lower end without any stone or mass lesions, and distended gallbladder with sludge. Triple-phase computed tomography revealed dilated CBD and PD measuring 12 and 8 mm, respectively, till lower end without any mass lesion ([Fig. 1]). Magnetic resonance cholangiopancreatography showed dilatation of bilobar intrahepatic biliary radicles, bile duct, and PD without any mass lesion ([Fig. 2]). Endoscopic US (EUS) ([Video 1]) was performed that showed dilated CBD and PD till ampulla without any mass lesion or stone, smooth symmetrical narrowing of bile duct and PD at papilla, symmetrically thickened ampullary without any mass lesion ([Fig. 3]), and normal pancreatic parenchyma without any evidence of chronic pancreatitis. Based on clinical, biochemical and imaging findings, differential diagnoses of ampullary neoplasm and SOD were considered. Human immunodeficiency virus serology was negative. Clinical history was revisited, which revealed significant opium intake for the last 20 years for recreational purpose. Based on clinical findings, imaging, and EUS, patient was suspected to have SOD, and decision to perform endoscopic retrograde cholangiopancreatography (ERCP) and sphincterotomy was taken after explaining the procedure details and possible complications to the patient. Side-view endoscopy revelated stenotic opening ([Fig. 4]) at the papilla, which could be cannulated with maneuvering. Endoscopic papillotomy was performed that also revealed thick ampullary muscle. ([Video 1]) Ampullary biopsy was taken which did not reveal dysplasia or malignancy ([Fig. 5]).

Zoom Image
Fig. 1 Computed tomography findings showing double duct sign.
Zoom Image
Fig. 2 Magnetic resonance cholangiopancreatography findings showing double duct sign.
Zoom Image
Fig. 3 Endoscopic ultrasound showing double duct in the absence of mass lesion and smooth tapering of ducts.
Zoom Image
Fig. 4 Side-view endoscopy showing stenotic and thickened papilla.
Zoom Image
Fig. 5 Ampullary biopsy—negative for malignancy or granuloma.

Patient was discharged after 24 hours of the procedure and was symptom free after 3 months of procedure. Repeat investigations revealed normalization of liver function test and Ca 19-9. Patient was advised to stop the opium intake and was advised for enrollment in a de-addiction clinic. He is under continuous follow-up to rule out the possibility of occult biliary malignancy.


#

Discussion

Dilated pancreatic and common bile duct (double duct sign) commonly occur due to periampullary malignancy. Chronic pancreatitis and SOD are possible benign differentials that should be considered in patients without mass lesion on imaging.

SOD refers to an abnormality of Sphincter of Oddi contractility causing obstruction to the flow of bile or pancreatic juices.[3] Sphincter of Oddi manometry had been identified as a gold standard for diagnosis of SOD; however, it is invasive and associated with morbidity and hence has been largely abandoned. Patients with type 1 SOD should be treated with endoscopic sphincterotomy without manometry.[4]

In our case, SOD was considered as likely possibility due to significant history of opium intake and absence of mass lesion or chronic pancreatitis on imaging. EUS is an important investigation to diagnose this condition by ruling out other etiologies such as neoplastic lesions or chronic pancreatitis.[5] Other EUS findings supporting the diagnosis were smooth symmetrical narrowing of ducts at ampulla and symmetrically thickened ampullary muscles. ERCP findings of circumferential thickening of ampullary muscle also supported the diagnosis of SOD.

Morphine and its derivatives can increase sphincter tone and result in SOD.[6] [7] Morphine use can cause a rise in basal pressure of sphincter of Oddi along with a rise in amplitude and frequency of phasic contractions. CBD pressures have also been shown to increase after morphine intake. Hence, opium deaddiction forms a cornerstone in the management of opium-induced SOD as it helps to reverse the pharmacological effects of morphine. However, prolonged opium use can also lead to bulky tumorous changes in ampulla with ulceration.[8] In such cases, long-term improvement has been seen after endoscopic sphincterotomy.[7] [9] Therefore, a history of opium abuse must be sought in every patient presenting with double duct sign without evidence of a mass lesion causing ampullary obstruction.


#

Conclusion

Opium intake can lead to SOD and dilated PD and bile duct. EUS is an important diagnostic modality in such cases to rule out small ampullary tumors. Endoscopic sphincterotomy can lead to long-term relief of symptoms in patients with SOD.

Video 1 0:00-0:34: Endoscopic ultrasound examination revealed dilated bile duct and pancreatic duct with smooth narrowing at ampulla, symmetrical thickening of ampullary muscle without any mass lesion. 0:34-1:23: Cannulation of stenotic ampulla. 1:23- 2:18: Endoscopic sphincterotomy with balloon sweep of bile duct.


Quality:

#
#

Conflict of Interest

None declared.

  • References

  • 1 Plumley TF, Rohrmann CA, Freeny PC, Silverstein FE, Ball TJ. Double duct sign: reassessed significance in ERCP. AJR Am J Roentgenol 1982; 138 (01) 31-35
  • 2 Staritz M. Pharmacology of the sphincter of Oddi. Endoscopy 1988; 20 (Suppl. 01) 171-174
  • 3 Mousavi S, Toussy J, Zahmatkesh M. Opium addiction as a new risk factor of sphincter of Oddi dysfunction. Med Sci Monit 2007; 13 (11) CR528-CR531
  • 4 Hall TC, Dennison AR, Garcea G. The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review. Langenbecks Arch Surg 2012; 397 (06) 889-898
  • 5 Sharma V, Rana SS, Chaudhary V. et al. Opium-related sphincter of Oddi dysfunction causing double duct sign. Endosc Ultrasound 2016; 5 (04) 269-271
  • 6 Wu SD, Zhang ZH, Jin JZ. et al. Effects of narcotic analgesic drugs on human Oddi's sphincter motility. World J Gastroenterol 2004; 10 (19) 2901-2904
  • 7 Sharma SS. Sphincter of Oddi dysfunction in patients addicted to opium: an unrecognized entity. Gastrointest Endosc 2002; 55 (03) 427-430
  • 8 Mohammad Alizadeh AH, Shams Afzali E, Sanati A, Shahnazi A, Mirsattari D, Zali MR. Cholangiographic features in opium-addicted patients at a tertiary hospital in Iran. Gastroenterol Res Pract 2012; 2012: 510536
  • 9 Helm JF, Venu RP, Geenen JE. et al. Effects of morphine on the human sphincter of Oddi. Gut 1988; 29 (10) 1402-1407

Address for correspondence

Akash Goel, MBBS DNB (Medicine) DrNB (Gastroenterology)
H-12/15 First floor, Malviya Nagar, Delhi 110017
India   

Publication History

Article published online:
27 May 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Plumley TF, Rohrmann CA, Freeny PC, Silverstein FE, Ball TJ. Double duct sign: reassessed significance in ERCP. AJR Am J Roentgenol 1982; 138 (01) 31-35
  • 2 Staritz M. Pharmacology of the sphincter of Oddi. Endoscopy 1988; 20 (Suppl. 01) 171-174
  • 3 Mousavi S, Toussy J, Zahmatkesh M. Opium addiction as a new risk factor of sphincter of Oddi dysfunction. Med Sci Monit 2007; 13 (11) CR528-CR531
  • 4 Hall TC, Dennison AR, Garcea G. The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review. Langenbecks Arch Surg 2012; 397 (06) 889-898
  • 5 Sharma V, Rana SS, Chaudhary V. et al. Opium-related sphincter of Oddi dysfunction causing double duct sign. Endosc Ultrasound 2016; 5 (04) 269-271
  • 6 Wu SD, Zhang ZH, Jin JZ. et al. Effects of narcotic analgesic drugs on human Oddi's sphincter motility. World J Gastroenterol 2004; 10 (19) 2901-2904
  • 7 Sharma SS. Sphincter of Oddi dysfunction in patients addicted to opium: an unrecognized entity. Gastrointest Endosc 2002; 55 (03) 427-430
  • 8 Mohammad Alizadeh AH, Shams Afzali E, Sanati A, Shahnazi A, Mirsattari D, Zali MR. Cholangiographic features in opium-addicted patients at a tertiary hospital in Iran. Gastroenterol Res Pract 2012; 2012: 510536
  • 9 Helm JF, Venu RP, Geenen JE. et al. Effects of morphine on the human sphincter of Oddi. Gut 1988; 29 (10) 1402-1407

Zoom Image
Fig. 1 Computed tomography findings showing double duct sign.
Zoom Image
Fig. 2 Magnetic resonance cholangiopancreatography findings showing double duct sign.
Zoom Image
Fig. 3 Endoscopic ultrasound showing double duct in the absence of mass lesion and smooth tapering of ducts.
Zoom Image
Fig. 4 Side-view endoscopy showing stenotic and thickened papilla.
Zoom Image
Fig. 5 Ampullary biopsy—negative for malignancy or granuloma.